Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 35.45% Profit, Reflecting QuantWave's Accuracy

June 07, 2024
ELI LILLY AND COMPANY, a leading pharmaceutical company, recently achieved the price target forecast set by QuantWave with impressive results. On the forecast signal date of January 23, 2024, the stock was trading at 623.24 $. The prediction indicated a long position, which proved to be accurate when the target price of 844.21 $ was reached on June 7, 2024, resulting in a substantial profit of 35.45%.

This success highlights the accuracy and reliability of QuantWave's forecasting algorithm, providing investors with valuable insights for informed decision-making. The achievement of the price target for ELI LILLY AND COMPANY demonstrates the platform's ability to analyze market trends and predict stock movements effectively.

Several factors may have contributed to the stock's movement, including positive developments in the pharmaceutical industry, company-specific news, or broader market trends. By leveraging QuantWave's analytical tools, investors were able to capitalize on these opportunities and generate significant returns.

QuantWave is a sophisticated automated forecasting platform that offers predictions for a wide range of stocks, presenting users with potential profit-making opportunities. For investors interested in enhancing their understanding of the platform's strategies, QuantSchool provides comprehensive educational resources on professional investment frameworks. QuantSchool equips users with the key principles for generating consistent income using the QuantWave forecasting system, empowering them to make informed investment decisions.

Overall, ELI LILLY AND COMPANY's attainment of the price target forecast with a 35.45% profit exemplifies the efficacy of QuantWave's analytics and reinforces its position as a valuable tool for investors seeking financial success in the stock market.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....


LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....


LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....


LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....


LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....


LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....


LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....


CRMDecember 18, 2023SALESFORCE, INC. Stock Hits QuantWave's Price Target Forecast with 22.2% Profit  ~1 min.

SALESFORCE, INC. (CRM) investors rejoiced as QuantWave's forecast signal successfully reached its price target, delivering a substantial 22.2% profit....


GSKFebruary 5, 20259.43% Profit Achieved: GSK PLC Hits Price Target Forecast on QuantWave  ~1 min.

On December 11, 2024, QuantWave's automated forecasting platform issued a long signal for GSK PLC with a price of $33.69....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....


FORDJuly 28, 2025QuantWave Hits Bullseye with 79.68% Profit on FORWARD INDUSTRIES, INC. Forecast  ~2 min.

In a remarkable display of accuracy, QuantWave's automated forecasting platform successfully predicted a long position for FORWARD INDUSTRIES, INC. with a profit of 79.68%....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....